Blog
Published April 8, 2025
A Massive Change in Customer Relationship Management (CRM) Software
The split between Veeva and Salesforce marks a significant shift in the CRM landscape.
Veeva is removing its CRM from the Salesforce cloud in September 2025 to focus on its “Veeva Vault” cloud solution for CRM. Veeva has communicated that it will maintain the current CRM product until September 2030 but will not be making any updates—and that it will absorb the cost of migration to the new Vault platform for…
Read Now
Blog
Published March 27, 2025
Trinity Life Sciences and Snowflake recently released an exciting blog highlighting a case study that illustrates how their partnership built the data foundation for Trinity RealWorldEDGE and Real Insights. These offerings enable clients to quickly and easily access patient-level data from any source for insight generation–and allow clients to unlock the potential of predictive insights grounded in market research and real-world data.
Excerpt
How did Snowflake and Snowpark transform Trinity’s vision into reality?
Data collaboration is critical to the success…
Read Now
Blog
Published March 19, 2025
Medical Affairs teams are increasingly harnessing the power of omnichannel communication and orchestrated customer engagement to enhance interactions with key stakeholders. Changing customer preferences and access to content are key factors Medical Affairs teams are addressing by adopting more customer engagement channels. As these capabilities continue to expand, it is important for teams to embrace a strategic mix of field medical engagements, digital platforms, personalized messaging, non-personal engagement and seamless coordination across channels.
By adopting an omnichannel strategy, Medical Affairs…
Read Now
Blog
Published February 27, 2025
We’re delighted to bring an external expert perspective to the “One Chapter Ahead” blog series and the important topic of culture and collaboration. Amy Saunders is a recognized customer experience global leader across life science verticals including pharma, med devices and consumer packaged goods (CPG) for companies such as J&J Consumer, W.L. Gore and Novartis. Most recently, Amy established and led the Customer Experience function at Novartis International which encompassed customer experience (Cx) strategy, engagement planning and production, patient support…
Read Now
Blog
Published February 5, 2025
How can pharma brands connect digital marketing experiences to achieve truly transformational customer engagement?
Brands that are leading the way demonstrate a complete grasp of fundamental digital marketing concepts and drive innovation in the ways that they engage customers. These brands maintain consistency in their message and interactions but tailor them to customer specific needs—and the innovation differentiates them in a market where many brands follow similar go-to-market strategies.
By exploring new ways of engagement in existing channels, they create…
Read Now
Blog
Published January 28, 2025
Health equity continues to be a hot topic in the life sciences industry. ISPOR EU sessions addressed several key questions surrounding the impact of health equity on HTA decision-making, the methodologies that should be employed, and the opportunities and challenges of incorporating health equity into health technology assessment (HTA).
Ahead of ISPOR EU, Trinity’s HTA Vision team analyzed the impact of health equity on HTA agency behavior across six recent pharmaceutical launches and seven countries: Australia, Canada, England, France, Germany,…
Read Now
Blog
Published January 24, 2025
On January 20, 2025, CMS announced the set of fifteen drugs targeted for the second round of Maximum Fair Price (MFP) “negotiations” under IRA. With the outcomes of the first price “negotiations” announced only last August, the IRA MFP process is still in its early development and there remains uncertainty over how it will evolve – particularly in terms of the extent to which CMS will aim for true drug cost reductions vs. generating political capital via nominal “savings” on…
Read Now
Blog
Published January 21, 2025
Trinity recently presented a poster on climate resilience and environmental sustainability at ISPOR EU, titled “Attitudes and Perceptions on Environmental Sustainability Efforts in the Life Sciences Industry: A Cross-Sectional Survey from HEOR and Industry Professionals.” The poster discussed results from a recent survey conducted by our CREST (Climate Resilience and Environmental Sustainability at Trinity) team, which identified perceptions regarding life sciences industry efforts to tackle sustainability, particularly within HEOR, evidence generation and value communication strategy. We also published our new…
Read Now
Blog
Published January 17, 2025
One trend Trinity Life Sciences has observed and that was reinforced by stakeholders at ISPOR EU is the importance of evidence in healthcare decision-making. This trend was highlighted particularly in the context of joint clinical assessments (JCA) and health technology assessments (HTA). Trinity presented 11 posters at ISPOR EU, 6 of which focused on HTA and/or JCA.
JCA is an EU initiative intended to improve patient access to health technologies in Europe through a harmonized clinical HTA process. Beginning in January…
Read Now
Blog
Published January 10, 2025
Cell and gene therapies (CGTs) have ushered in a new era of medicine, offering patients transformative, even potentially curative solutions, with a single treatment. Despite the clinical promise, barriers to patient access remain given administration complexity, gaps in patient outcome evidence and high costs. As cell and gene therapies become available in new indications beyond oncology and rare pediatric diseases, developers of innovative therapies need to develop strategies targeting patients, providers and payers to overcome these challenges and promote access…
Read Now
